HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holm, A. M. Articles by Frøland, S. S. Search for Related Content PubMed PubMed Citation Articles by Holm, A. M. Articles by Frøland, S. S. Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB THEOPHYLLINE

Impaired Secretion of IL-10 by T Cells from Patients with Common Variable Immunodeficiency–Involvement of Protein Kinase A Type I¹

Are Martin Holm^2,*, Pål Aukrust^*,, Einar Martin Aandahl, Fredrik Müller^*,, Kjetil Taskén and Stig S. Frøland^*,

^* Research Institute for Internal Medicine, Section for Clinical Immunology and Infectious Diseases, Medical Department, and Department of Microbiology, National Hospital, and Department of Medical Biochemistry, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway

Common variable immunodeficiency (CVID) is a heterogeneous group of B cell deficiency syndromes. T cell abnormalities are present in a high proportion of patients with CVID, suggesting impaired T cell-mediated stimulation of B cells. Based on the importance of IL-10 for B cell function and the involvement of the cAMP/protein kinase A type I (PKAI) system in IL-10 synthesis, we examined IL-10 secretion in T cells from CVID patients and controls, particularly focusing on possible modulatory effects of the cAMP/PKAI system. Our main findings were: 1) anti-CD3 and anti-CD3/anti-CD28 activated T cells from CVID patients secreted less IL-10 than healthy controls. This defect was not related to varying proportions of T cell subsets (e.g., CD4⁺/CD8⁺, CD45RA⁺/RO⁺, or CD28^- T cells); 2) PKAI activation through the cAMP agonist 8-CPT-cAMP markedly inhibited IL-10 secretion from T cells through CD3 and CD28 activation in both patients and controls, but the sensitivity for cAMP-dependent inhibition was increased in CVID; 3) selective PKAI inhibition by Rp-8-Br-cAMPS markedly increased IL-10 secretion in anti-CD3 and anti-CD3/anti-CD28-stimulated T cells in both patients and controls. Even at the lowest concentrations of Rp-8-Br-cAMPS, IL-10 secretion in CVID patients reached levels comparable to those in controls. Our findings suggest impaired secretion of IL-10 by T cells from CVID patients, suggesting a possible link between T cell deficiency and impaired B cell function in CVID. The involvement of the cAMP/PKAI system in this defect suggests a novel target for therapeutic immunomodulation in CVID.

This article has been cited by other articles:

				S. R. Paccani, M. Boncristiano, L. Patrussi, C. Ulivieri, A. Wack, S. Valensin, T. R. Hirst, A. Amedei, G. del Prete, J. L. Telford, et al. Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects Blood, July 15, 2005; 106(2): 626 - 634. [Abstract] [Full Text] [PDF]

				A. M. Holm, P. Aukrust, J. K. Damas, F. Muller, B. Halvorsen, and S. S. Froland Abnormal interleukin-7 function in common variable immunodeficiency Blood, April 1, 2005; 105(7): 2887 - 2890. [Abstract] [Full Text] [PDF]